Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Yao-Jie Pan"'
Autor:
Fu-Chun Huo, Zhi-Man Zhu, Wen-Qi Du, Yao-Jie Pan, Xin Jiang, Meng-Jie Kang, Bo-Wen Liu, Jie Mou, Dong-Sheng Pei
Publikováno v:
Pharmacological Research, Vol 195, Iss , Pp 106863- (2023)
Human papillomavirus (HPV) infection is a causative agent of cervical cancer (CC). N6-methyladenosine (m6A) modification is implicated in carcinogenesis and tumor progression. However, the involvement of m6A modification in HPV-involved CC remains un
Externí odkaz:
https://doaj.org/article/216043fbd7b048acbb07e9fcf98c8a38
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 11, Pp n/a-n/a (2022)
Abstract Background Dysregulation of alternative splicing (AS) induced by serine/arginine‐rich proteins has recently been linked to cancer metastasis. Nonetheless, as a member of the serine/arginine‐rich protein family, the involvement of SRSF11
Externí odkaz:
https://doaj.org/article/b2d9bdadf4a64314ae7ac29d30aed282
Autor:
Tong-tong Li, Jie Mou, Yao-jie Pan, Fu-chun Huo, Wen-qi Du, Jia Liang, Yang Wang, Lan-sheng Zhang, Dong-sheng Pei
Publikováno v:
Journal of Biomedical Science, Vol 28, Iss 1, Pp 1-19 (2021)
Abstract Background Sorafenib is a kinase inhibitor that is used as a first-line therapy in advanced hepatocellular carcinoma (HCC) patients. However, the existence of sorafenib resistance has limited its therapeutic effect. Through RNA sequencing, w
Externí odkaz:
https://doaj.org/article/dc50049f40874faa8ed556f2aad388f9
Autor:
Jin-Xia Wu, Wen-Qi Du, Xiu-Cun Wang, Lu-Lu Wei, Fu-Chun Huo, Yao-Jie Pan, Xiao-Jin Wu, Dong-Sheng Pei
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-3 (2021)
Externí odkaz:
https://doaj.org/article/fdf5058f650f42daa73cb7db12bfdd16
Autor:
Ying-Chun Zhang, Fu-Chun Huo, Lu-Lu Wei, Chan-Chan Gong, Yao-Jie Pan, Jie Mou, Dong-Sheng Pei
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 36, Iss 1, Pp 1-13 (2017)
Abstract Background Abnormal proliferation is significantly associated with the promotion of malignant tumor. Growing evidence suggest that the signal pathways of p21cdc42/rac1-activated kinase 5 (PAK5) have been found in various tumor progression, h
Externí odkaz:
https://doaj.org/article/da120f8b3aa84f42a3a6f573f9619c00
Autor:
Jin-Xia Wu, Wen-Qi Du, Xiu-Cun Wang, Lu-Lu Wei, Fu-Chun Huo, Yao-Jie Pan, Xiao-Jin Wu, Dong-Sheng Pei
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Abstract Rap2a, a member of the small GTPase superfamily, belongs to Ras superfamily, and its function in cancer progression is still poorly understood. Our previous study indicated that the ectopic expression of Rap2a enhanced the migration and inva
Externí odkaz:
https://doaj.org/article/15b014946b634533945d80ccb1662a04
Autor:
Bo-Wen Liu, Angxi Song, Pengkun Gui, Jin Wang, Yao-Jie Pan, Chao Li, Shuai Li, Yi Zhang, Tao Jiang, Yi-Xin Xu, Fu-Chun Huo, Dong-Sheng Pei, Jun Song
Long noncoding RNAs (lncRNAs) play critical roles in tumorigenesis and tumor metastasis. However, the underlying mechanisms of lncRNAs in colorectal cancer (CRC) need further exploration. By using data from The Cancer Genome Atlas (TCGA) and GEO data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b5272ba3d4814ed6ed7edcc655cc992
https://doi.org/10.21203/rs.3.rs-2419501/v1
https://doi.org/10.21203/rs.3.rs-2419501/v1
Publikováno v:
DNA and cell biology. 41(9)
[Formula: see text] Alternative splicing (AS) can generate distinct transcripts and subsequent isoforms that play differential functions from the same pre-mRNA. Recently, increasing numbers of studies have emerged, unmasking the association between A
Publikováno v:
Cancer Management and Research. 11:10411-10418
MicroRNAs (miRNAs) are small non-coding and highly conserved RNAs that act in biological processes including cell proliferation, invasion, apoptosis, metabolism, signal transduction, and tumorigenesis. The previously identified miRNA-326 (miR-326) ha
Autor:
Yang Wang, Fu-Chun Huo, Wen-Qi Du, Dong-Sheng Pei, Tong-Tong Li, Yao-Jie Pan, Jia Liang, Lan-Sheng Zhang, Jie Mou
Publikováno v:
Journal of Biomedical Science, Vol 28, Iss 1, Pp 1-19 (2021)
Journal of Biomedical Science
Journal of Biomedical Science
Background Sorafenib is a kinase inhibitor that is used as a first-line therapy in advanced hepatocellular carcinoma (HCC) patients. However, the existence of sorafenib resistance has limited its therapeutic effect. Through RNA sequencing, we demonst